Targeted radiotherapy in the conditioning prior to haematopoietic stem cell transplantation: Results of a phase I trial using an yttrium-90-labelled anti-CD66 murine monoclonal antibody demonstrating consistently high BM uptake

Phase I ◽

Cell Transplantation ◽

Phase I Trial ◽

Targeted Radiotherapy ◽

Yttrium 90

Targeted radiotherapy delivered by an yttrium-90 radio-labelled Anti-CD66 monoclonal antibody with high dose melphalan compared to melphalan alone, prior to autologous stem cell transplantation for multiple myeloma

http://isrctn.org/> ◽

10.1186/isrctn11933044 ◽

2012 ◽

Author(s):

Kim Orchard

Keyword(s):

Multiple Myeloma ◽

Monoclonal Antibody ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Targeted Radiotherapy ◽

High Dose Melphalan ◽

Yttrium 90

Orphan designation: Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2, Treatment in haematopoietic stem cell transplantation

10.31525/cmr-6ac714 ◽

2018 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Serine Protease ◽

Cell Transplantation ◽

Human Monoclonal Antibody ◽

Mannan Binding Lectin ◽

Binding Lectin

Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-021-05630-7 ◽

2021 ◽

Author(s):

Rie Kuroda ◽

Hiroshi Wakabayashi ◽

Raita Araki ◽

Anri Inaki ◽

Ryosei Nishimura ◽

...

Keyword(s):

Clinical Trial ◽

Stem Cell ◽

High Risk ◽

Phase I ◽

Cell Transplantation ◽

High Dose ◽

Myeloablative Chemotherapy

Orphan designation: Radio-iodinated (131I) anti-CD45 murine monoclonal antibody, Treatment in haematopoietic stem cell transplantation

10.31525/cmr-10f5e3f ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Cell Transplantation ◽

Murine Monoclonal Antibody ◽

Antibody Treatment ◽

Orphan Designation ◽

Monoclonal Antibody Treatment

Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.2005.02806.x ◽

2005 ◽

Vol 141 (1) ◽

pp. 1-9 ◽

Cited By ~ 69

Author(s):

A. Tyndall ◽

R. Saccardi

Keyword(s):

Stem Cell ◽

Autoimmune Disease ◽

Phase I ◽

Cell Transplantation ◽

Randomized Trials ◽

Future Directions

Phase I trial of yttrium 90 ibritumomab tiuxetan (90Y-RIT) with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8565 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8565-8565 ◽

Cited By ~ 1

Author(s):

L. J. Swinnen ◽

I. W. Flinn ◽

B. S. Kahl ◽

E. Frey ◽

K. Rogers ◽

...

Keyword(s):

Stem Cell ◽

Phase I ◽

B Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase I Trial ◽

Hodgkin's Lymphoma ◽

Ibritumomab Tiuxetan ◽

Yttrium 90

Orphan designation: Radio-iodinated (131I) anti-CD45 murine monoclonal antibody, Treatment in haematopoietic stem cell transplantation

10.31525/cmr-10f7bcb ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Cell Transplantation ◽

Murine Monoclonal Antibody ◽

Antibody Treatment ◽

Orphan Designation ◽

Monoclonal Antibody Treatment

Orphan designation: Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2, Treatment in haematopoietic stem cell transplantation

10.31525/cmr-6939fa ◽

2018 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Stem Cell ◽

Serine Protease ◽

Cell Transplantation ◽

Human Monoclonal Antibody ◽

Mannan Binding Lectin ◽

Binding Lectin

CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan

Arthritis Research & Therapy ◽

10.1186/s13075-019-1823-0 ◽

2019 ◽

Vol 21 (1) ◽

Cited By ~ 7

Author(s):

Masahiro Ayano ◽

Hiroshi Tsukamoto ◽

Hiroki Mitoma ◽

Yasutaka Kimoto ◽

Mitsuteru Akahoshi ◽

...

Keyword(s):

Clinical Trial ◽

Stem Cell ◽

Systemic Sclerosis ◽

Phase I ◽

Cell Transplantation ◽

Post Hoc Analysis ◽

Post Hoc

Cost-effectiveness analysis of prophylaxis therapies for invasive fungal infections following allogeneic haematopoietic stem cell transplantation in Mexico

10.26226/morressier.56d6be7bd462b80296c957c2 ◽

2016 ◽

Author(s):

Claudie Charbonneau

Keyword(s):

Stem Cell ◽

Cost Effectiveness ◽

Cell Transplantation ◽

Fungal Infections ◽

Cost Effectiveness Analysis ◽

Invasive Fungal Infections ◽

Effectiveness Analysis